Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 27 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Omega-3 fatty acids in aromatase inhibitor-associated dyslipidemia: mechanisms, clinical evidence, and future perspectives
    Ruiqi Chen, Minghao Xiong, Shengchao Huang
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  2. Circulating tumor DNA in Hodgkin lymphoma: biological classification, molecular residual disease, and integration with PET response
    Marta Bednarek, Maria Komossa, Joanna Bidzińska
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  3. Risk factors for non-sentinel lymph node metastasis in breast cancer: a meta-analysis
    Lan Xu, Kaiyue Wang, Ziwei Chen +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  4. Beyond XAI: a claim-specific translation matrix for cancer biomarkers and therapeutic targets
    Vijayachitra Modhukur, Naisarg Patel, Prakash Lingasamy
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  5. Efficacy and safety of thymosin combined with anticancer therapy for colorectal cancer: a systematic review and meta-analysis of controlled studies
    Guannan Zhang, Yuxin Zhou, Tao Sun +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  6. Extent of lymphadenectomy dictates adjuvant chemotherapy benefit in primarily resected esophageal squamous cell carcinoma: a multi-cohort validation
    Yicheng Huang, Xuanhao Lin, Yanhong Lin +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  7. The clinical and biological significance of TBRG4 expression in prostate cancer
    Wenxuan Li, Xi Xiao, Ting Wang +10
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  8. Editorial: AI-powered insights: predicting treatment response and prognosis in breast cancer
    Tamer Ahmed Farrag, Ashraf Elbatanony, Mona Zaky +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  9. Insulin-like growth factor-1 receptor participates in the anti-MDS action involving the MICA/B-NKG2D axis
    Xiaohan Liu, Lei Huang, Yixuan Guo +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  10. Intersphincteric resection versus transanal local excision after neoadjuvant therapy for ultra-low rectal cancer: a two-center retrospective propensity-score-adjusted cohort study
    Guan-cong Wang, Jia-hong Ye, Yin-cong Guo +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  11. Role and mechanism of ribosomal protein S3 in tyrosine kinase inhibitor resistance in chronic myeloid leukemia
    Zheng Sun, Sijin Liu, Yuxin Ning +10
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  12. Green synthesized plant mediated zinc oxide nanoparticles as potential nano phytotherapeutic agents for reactive oxygen species driven anticancer activity in HepG2 liver cancer cells
    Anupama Sharma, Lalit Prasad, Sandeep Kumar +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  13. Leser–Trélat sign associated with lung cancer: a case report and review of the literature
    Mei Xiong, Lengping Chen, Junwu Zhou
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  14. Development of evidence-based nursing recommendations for hand-foot syndrome in breast cancer chemotherapy patients
    Liuqin Huang, Haixia Lu, Ying Zhou +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  15. Concurrent splenic infarction and pulmonary embolism as the initial presentation of high-grade follicular lymphoma: a case report
    Qijiang Zhao, Chaoli Ding, Suping Wu +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  16. CT and MRI multimodality imaging features of endometrial stromal sarcoma: a retrospective single-center analysis of 35 pathologically confirmed cases
    Lan Yu, Meizhen Xie, Yan Dong +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  17. Digital health interventions for cognitive function in breast cancer patients treated with chemotherapy: a network meta-analysis of subjective and objective cognitive outcomes
    Ruihong Zeng, Xiangyu Liu, Yujia Fan +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  18. Percutaneous Insertion of Hepatic Arterial Infusion Ports by Interventional Radiology for Colorectal Liver Metastases
    Hugo C. Temperley, Omar Abu Saadeh, Padraig Cronin +9
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  19. Beyond BMI: Roles of SPISE, Central Adiposity and Body Composition in Pediatric Brain Tumor Survivors
    Amanda Casirati, Giacomo Tantari, Giuseppe D’Annunzio +16
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  20. Tumor Budding in Colorectal Cancer: Biological Basis, Clinical Risk Stratification, and Digital Pathology
    Enrique Bernal-Morell, Francisco Martínez-Díaz, Francisco García-Molina
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  21. Rethinking Surgical Margins in Colorectal Liver Metastases: Vessel-Skeletonized Parenchymal-Sparing Hepatectomy (VESPAH) and Treatment Continuity
    Yuzo Umeda, Tomokazu Fuji, Kosei Takagi +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  22. Residual DCIS Versus No Residual Breast Tumor After Neoadjuvant Chemotherapy in ypN0 Breast Cancer: A Retrospective Clinical, MRI, and Survival Comparison
    Özlem Mermut, Berrin Yalçın, Rıza Umar Gürsu +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  23. The Optimal Biological Therapy for Conversion in Patients with RAS-Wild-Type Colorectal Cancer and Unresectable Liver Metastases
    Miljana Džunić, Ivan Petković, Ana Cvetanović +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  24. Neoadjuvant Versus Adjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer: A National Cancer Database Study
    Taiga Komatsu, Rima Patel, Amy Tiersten
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  25. Treatment Effects of Different Therapeutic Strategies and Development of a Prognostic Prediction Model for Early Gastric Cancer: A Population-Based and Multicenter Study
    Ruiying Jing, Shimei Sun, Tian Tian +6
    CancersPeer-reviewedCC BY 4.0OncologyCrossref